Search Results - Dirk Garmann

Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII by João A. Abrantes, Alexander Solms, Dirk Garmann, Elisabet I. Nielsen, Siv Jönsson, Mats O. Karlsson

Connect to this object online.

Evaluation of covariate effects in item response theory models by Gustaf J. Wellhagen, Ashraf Yassen, Dirk Garmann, Astrid Bröker, Alexander Solms, Yang Zhang, Maria C. Kjellsson, Mats O. Karlsson

Connect to this object online.

Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea by Gustaf J. Wellhagen, Mats O. Karlsson, Maria C. Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen

Connect to this object online.

Copanlisib population pharmacokinetics from phase I-III studies and exposure-response relationships in combination with rituximab by Peter N. Morcos, Jonathan Moss, Rupert Austin, Florian Hiemeyer, Pier Luigi Zinzani, Vita Beckert, Lidia Mongay Soler, Barrett H. Childs, Dirk Garmann

Connect to this object online.

Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors by Peter N. Morcos, Jan Schlender, Rolf Burghaus, Jonathan Moss, Adam Lloyd, Barrett H. Childs, Margaret E. Macy, Joel M. Reid, John Chung, Dirk Garmann

Connect to this object online.

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling by Alexander Solms, Matthias Frede, Scott D. Berkowitz, Anne Hermanowski‐Vosatka, Dagmar Kubitza, Wolfgang Mueck, Theodore E. Spiro, Stefan Willmann, Xiaoyu Yan, Liping Zhang, Dirk Garmann

Connect to this object online.